Stock Pulse
Allstate (ALL) finalized the sale of its voluntary benefits and Group Health businesses for a combined $3.25 billion, resulting in a $625 million gain [7], [10]. The company will use the proceeds for share repurchases and capital management, including an increased quarterly dividend [7], [10]. Allstate is focusing on its core property and liability insurance business, aiming for growth and improved profitability through rate hikes and cost-cutting measures [3], [7], [8]. Despite positive developments like strong Q4 2024 results and anticipated revenue growth, the company faces challenges such as rising claims costs, high debt levels, and potential impacts from auto tariffs [2], [4]. Analysts maintain a "Hold" rating on the stock [2], [6], while some consider it undervalued due to a low Forward P/E ratio [2].